批准日期,申请提交历史,通知信,药品说明书,审评文件等信息
>>>原始批准或临时批准<<<
| 审批日期 | 提交号 | 审批结论 | 提交分类 | 审评优先级;罕用药状态 | 通知信、审评文件、说明书、包装标签 | 备注 |
| 1993/12/16 |
ORIG-1(原始申请) |
Approval |
Type 3 - New Dosage Form |
STANDARD
|
|
|
>>>补充申请<<<
| 审批日期 | 提交号 | 审批结论 | 补充类别或审批类型 | 审评优先级;罕用药状态 | 通知信、审评文件、说明书、包装标签 | 备注 |
| 2023/05/12 |
SUPPL-21(补充) |
Approval |
Labeling-Package Insert |
STANDARD
|
|
|
| 2017/08/15 |
SUPPL-19(补充) |
Approval |
Labeling-Package Insert,Labeling-Container/Carton Labels |
STANDARD
|
|
|
| 2016/06/06 |
SUPPL-18(补充) |
Approval |
Manufacturing (CMC) |
STANDARD
|
|
|
| 2013/03/04 |
SUPPL-16(补充) |
Approval |
Labeling-Package Insert |
STANDARD
|
|
|
| 2010/12/21 |
SUPPL-14(补充) |
Approval |
Labeling-Package Insert |
UNKNOWN
|
|
|
| 2007/04/26 |
SUPPL-11(补充) |
Approval |
Labeling |
STANDARD
|
|
|
| 2006/02/10 |
SUPPL-9(补充) |
Approval |
Manufacturing (CMC)-Packaging |
STANDARD
|
|
|
| 2000/02/08 |
SUPPL-7(补充) |
Approval |
Manufacturing (CMC)-Control |
STANDARD
|
|
|
| 1997/08/14 |
SUPPL-4(补充) |
Approval |
Manufacturing (CMC)-Packaging |
STANDARD
|
|
|
| 1997/07/16 |
SUPPL-6(补充) |
Approval |
Manufacturing (CMC)-Control |
STANDARD
|
|
|
| 1995/08/21 |
SUPPL-3(补充) |
Approval |
Manufacturing (CMC)-Packaging |
STANDARD
|
|
|
| 1994/07/13 |
SUPPL-2(补充) |
Approval |
Labeling |
STANDARD
|
|
|
| 1994/04/11 |
SUPPL-1(补充) |
Approval |
Manufacturing (CMC)-Control |
STANDARD
|
|
|
与本品相关的专利信息(来自FDA橙皮书Orange Book)
| 关联产品号 | 专利号 | 专利过期日 | 是否物质专利 | 是否产品专利 | 专利用途代码 | 撤销请求 | 提交日期 | 专利下载 | 备注 |
| 无 |
与本品治疗等效的药品
>>>活性成分:SUCRALFATE; 剂型/给药途径:SUSPENSION;ORAL; 规格:1GM/10ML; 治疗等效代码:AB<<<
| 申请号 | 产品号 | 申请类型 | 商品名 | 活性成分 | 剂型/给药途径 | 规格 | 市场状态 | RLD | RS | TE Code | 产品号批准日期 | 申请人 |
| 019183 |
001 |
NDA |
CARAFATE |
SUCRALFATE |
SUSPENSION;ORAL |
1GM/10ML |
Prescription |
Yes |
Yes |
AB |
1993/12/16
|
ABBVIE |
| 209356 |
001 |
ANDA |
SUCRALFATE |
SUCRALFATE |
SUSPENSION;ORAL |
1GM/10ML |
Prescription |
No |
No |
AB |
2019/12/02
|
AMNEAL |
| 211884 |
001 |
ANDA |
SUCRALFATE |
SUCRALFATE |
SUSPENSION;ORAL |
1GM/10ML |
Prescription |
No |
No |
AB |
2022/03/15
|
VISTAPHARM LLC |
| 212913 |
001 |
ANDA |
SUCRALFATE |
SUCRALFATE |
SUSPENSION;ORAL |
1GM/10ML |
Prescription |
No |
No |
AB |
2022/09/12
|
MYLAN |
| 213549 |
001 |
ANDA |
SUCRALFATE |
SUCRALFATE |
SUSPENSION;ORAL |
1GM/10ML |
Prescription |
No |
No |
AB |
2024/01/17
|
PD PARTNERS |
| 216726 |
001 |
ANDA |
SUCRALFATE |
SUCRALFATE |
SUSPENSION;ORAL |
1GM/10ML |
Prescription |
No |
No |
AB |
2024/03/21
|
ABON PHARMS LLC |
| 216474 |
001 |
ANDA |
SUCRALFATE |
SUCRALFATE |
SUSPENSION;ORAL |
1GM/10ML |
Prescription |
No |
No |
AB |
2024/05/21
|
STRIDES PHARMA |
| 212769 |
001 |
ANDA |
SUCRALFATE |
SUCRALFATE |
SUSPENSION;ORAL |
1GM/10ML |
Discontinued |
No |
No |
AB |
2024/07/23
|
HIKMA |
| 217126 |
001 |
ANDA |
SUCRALFATE |
SUCRALFATE |
SUSPENSION;ORAL |
1GM/10ML |
Prescription |
No |
No |
AB |
2024/11/13
|
COSETTE |
| 211780 |
001 |
ANDA |
SUCRALFATE |
SUCRALFATE |
SUSPENSION;ORAL |
1GM/10ML |
Prescription |
No |
No |
AB |
2025/04/14
|
PADAGIS US |